RENB — Stock activity · TradeandTellRENB
RENB
$1.42+$1.29 (+1,021.64%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$0.12 – $1.43
99% from low
Held by traders on TradeandTell
No one on the platform currently holds RENB.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in RENB as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded RENB yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Earnings surprises
Beat consensus in 0 of the last 5 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2024-11-14 | $1.52 | $-0.03 | -102.0% |
| 2024-10-09 | $1.32 | $-0.41 | -131.1% |
| 2024-05-15 | $1.55 | $-0.08 | -105.2% |
| 2023-11-14 | $1.52 | $-0.14 | -109.2% |
| 2023-09-29 | $1.32 | $-3.60 | -372.7% |
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| RENBLunai Bioworks Inc. | $1.42 | +0.00% | $33M | — |
| ALLKAllakos Inc. | $0.33 | +0.22% | $30M | — |
| ANGNAngion Biomedica Corp. | $1.00 | +0.00% | $30M | — |
| FRLNFreeline Therapeutics Holdings plc | $6.49 | +0.15% | $28M | — |
| GRCEGrace Therapeutics, Inc. | $2.07 | -1.43% | $34M | — |
| IRDOpus Genetics, Inc. | $3.72 | -1.06% | $307M | — |
Source: Financial Modeling Prep · peers by sector/industry
| LIANYLianBio | $0.04 | +0.00% | $4M | — |